Skip to content

Does Micropattern on Urinary Catheter Surface Reduce Urinary Tract Infections?

Does Micropattern on Urinary Catheter Surface Reduce Urinary Tract Infections?

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02835456
Acronym
SHARKLET
Enrollment
50
Registered
2016-07-18
Start date
2016-08-31
Completion date
2016-12-31
Last updated
2017-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter Associated Urinary Tract Infections

Keywords

CAUTI, Biofilm, Urinary tract infections, micropattern, Catheter

Brief summary

The aim of this study is to determine if the Sharklet catheter, with its unique surface micropattern, reduces infections in participants, when compared to a standard silicone catheter.

Detailed description

The aim of this study is to determine if the Sharklet catheter, with its unique surface micropattern, reduces infections in participants, when compared to a standard silicone catheter.

Interventions

DEVICESharklet Catheter insertion
DEVICESilicone Foley Catheter insertion

Sponsors

Cook Group Incorporated
CollaboratorINDUSTRY
Jahn Ferenc South Pest Teaching Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient requires a chronic indwelling Foley catheter for at least 3 days. * Catheters will not remain indwelling greater than 30 days at a time * Patient is more than 18 years of age * Patient is able to give informed consent * Patient is able to attend follow-up sessions

Exclusion criteria

* Patient is less than 18 years of age * Patient is pregnant * Patient with a known allergy to silicone * Patient has urinary tract anatomic abnormality that would prevent placement of a standard Foley catheter * Patient unable to accommodate the catheter * Patient has an active urinary tract infection (UTI) or other diagnosed infection that is untreated. * Patient currently taking (or expected to take) more than a single dose of antibiotics for prevention of other infections during the catheter indwell period * Patient has uncontrolled fecal incontinence (uncontrolled stool/poop passage) * Patient is unable to feel and/or communicate their symptoms * Informed consent is unable to be obtained * Patient is unable or unwilling to comply with the study follow-up schedule * Patient has a medical condition or disorder that would limit life expectancy to less than 30 days or that may cause non-compliance with the protocol or confound the data analysis * Any other reason that if in the opinion of the investigator would make the patient unsuitable for enrollment in the study

Design outcomes

Primary

MeasureTime frameDescription
Catheter scrapings examined for colonization/biofilm burden and compared to the urine screen collected from the participant (cfu/mL)12 weeksDetermine if there will be less adherent bacteria/biofilm to the Sharklet catheter compared to the controls.
Number of symptomatic Urinary tract infections (UTIs) determined by urine culture.12 weeksDetermine number of symptomatic UTIs between the 2 groups as determined by urine culture.

Secondary

MeasureTime frameDescription
Incidence of Discomfort12 weeksIncidence of significant discomfort/pain requiring removal
Surface analysis of the type of bacteria found on each catheter12 weeksSurface analysis (e.g., Scanning Electron Microscopy) of removed catheters for qualitative assessment of bacterial colonization
Incidence of bacteremia12 weeksIncidence of bacteremia following CA-SUTI
Surface analysis of the biofilm formation12 weeksSurface analysis (e.g., Scanning Electron Microscopy) of removed catheters for qualitative assessment of biofilm formation
Surface analysis of the amount of encrustation12 weeksSurface analysis (e.g., Scanning Electron Microscopy) of removed catheters for qualitative assessment of encrustation
Incidence of Crustation12 weeksIncidence of catheter obstruction/encrustation requiring removal

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026